Bollard Group’s Acceleron Pharma XLRN Stock Holding History

Bollard Group’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-880	Closed	-$151K	–	444
2021 Q3	$151K	Hold	880	–	–	﹤0.01%	253
2021 Q2	$110K	Hold	880	–	–	﹤0.01%	273
2021 Q1	$119K	Hold	880	–	–	﹤0.01%	261
2020 Q4	$113K	Hold	880	–	–	﹤0.01%	249
2020 Q3	$99K	Hold	880	–	–	﹤0.01%	250
2020 Q2	$84K	Buy	+880	New	+$84.8K	﹤0.01%	273

Bollard Group's XLRN Position: Q4 2021 in Review

Bollard Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 880 shares — an estimated $151K sold.

Bollard Group first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $151K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Bollard Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Bollard Group sold 880 Acceleron Pharma shares in Q4 2021, an estimated $151K.
Bollard Group first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
Bollard Group's Acceleron Pharma position peaked at $151K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Bollard Group's 13F filing for Q4 2021, filed 11 Feb 2022.